全文获取类型
收费全文 | 908篇 |
免费 | 44篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 7篇 |
妇产科学 | 5篇 |
基础医学 | 133篇 |
口腔科学 | 12篇 |
临床医学 | 161篇 |
内科学 | 192篇 |
皮肤病学 | 16篇 |
神经病学 | 45篇 |
特种医学 | 57篇 |
外科学 | 163篇 |
综合类 | 5篇 |
一般理论 | 1篇 |
预防医学 | 20篇 |
眼科学 | 24篇 |
药学 | 35篇 |
中国医学 | 2篇 |
肿瘤学 | 61篇 |
出版年
2023年 | 5篇 |
2022年 | 14篇 |
2021年 | 19篇 |
2020年 | 15篇 |
2019年 | 19篇 |
2018年 | 32篇 |
2017年 | 17篇 |
2016年 | 20篇 |
2015年 | 22篇 |
2014年 | 39篇 |
2013年 | 60篇 |
2012年 | 66篇 |
2011年 | 59篇 |
2010年 | 42篇 |
2009年 | 42篇 |
2008年 | 48篇 |
2007年 | 58篇 |
2006年 | 61篇 |
2005年 | 44篇 |
2004年 | 38篇 |
2003年 | 39篇 |
2002年 | 37篇 |
2001年 | 12篇 |
2000年 | 18篇 |
1999年 | 17篇 |
1998年 | 6篇 |
1997年 | 8篇 |
1995年 | 6篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 12篇 |
1991年 | 7篇 |
1990年 | 7篇 |
1989年 | 9篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1982年 | 2篇 |
1980年 | 2篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1974年 | 3篇 |
1972年 | 6篇 |
1971年 | 3篇 |
1970年 | 3篇 |
1969年 | 2篇 |
1968年 | 4篇 |
1966年 | 3篇 |
排序方式: 共有966条查询结果,搜索用时 15 毫秒
1.
The antiviral agent foscarnet has long been used in our unit to treat cytomegalovirus (CMV) infections in renal transplant
patients. The clinical effect has been convincing and, apart from changes in serum calcium levels, very few side effects have
been noted. We have, however, observed a nephrotoxic reaction in a series of patients with initially good renal function who
therefore received high doses of foscarnet. Transplant biopsies performed in five of those patients revealed degenerative
changes in the tubular epithelial cells as well as tubular calcium deposits and an infiltration of the interstitium by mixed
mononuclear and polymorphonuclear leucocytes. Renal insufficiency was accompanied by high fever. After withdrawal of the drug,
the temperature rapidly normalized, whereas serum creatinine continued to rise for about 3 days and then fell back towards
previous levels. We conclude that transplant biopsies are of great value in distinguishing between a foscarnet nephrotoxic
effect and CMV nephritis, various forms of rejection, and other causes of impaired renal function. 相似文献
2.
A technique for respiratory-gated radiotherapy treatment verification with an EPID in cine mode 总被引:1,自引:0,他引:1
Berbeco RI Neicu T Rietzel E Chen GT Jiang SB 《Physics in medicine and biology》2005,50(16):3669-3679
Respiratory gating based on external surrogates is performed in many clinics. We have developed a new technique for treatment verification using an electronic portal imaging device (EPID) in cine mode for gated 3D conformal therapy. Implanted radiopaque fiducial markers inside or near the target are required for this technique. The markers are contoured on the planning CT set, enabling us to create digitally reconstructed radiographs (DRRs) for each treatment beam. During the treatment, a sequence of EPID images can be acquired without disrupting the treatment. Implanted markers are visualized in the images and their positions in the beam's eye view are calculated off-line and compared to the reference position by matching the field apertures in corresponding EPID and DRR images. The precision of the patient set-up, the placement of the beam-gating window, as well as the residual tumour motion can be assessed for each treatment fraction. This technique has been demonstrated with a case study patient, who had three markers implanted in his liver. For this patient, the intra-fractional variation of all marker positions in the gating window had a 95% range of 4.8 mm in the SI direction (the primary axis of motion). This was about the same (5 mm) as the residual motion considered in the planning process. The inter-fractional variation of the daily mean positions of the markers, which indicates the uncertainty in the set-up procedure, was within +8.3 mm/-4.5 mm (95% range) in the SI direction for this case. 相似文献
3.
4.
Ghrelin is a novel peptide that stimulates the release of growth hormone from the pituitary and is involved in hypothalamic feeding regulation. A pre-embedding immunostaining technique was used to study the ultrastructure and synaptic relationships of ghrelin-containing neurons in the rat arcuate nucleus (ARC). Ghrelin-like immunoreactive (ghrelin-LI) neurons were found in the ARC, and were especially abundant in its ventral part. At the electron microscopic level, ghrelin-LI neurons received afferent synapses from many unknown axon terminals. Ghrelin-LI products in the immunoreactive cell bodies, processes, and axon terminals were detected mainly in dense granular vesicles about 110 nm in diameter. Ghrelin-LI presynaptic axon terminals often made synapses with unknown immunonegative neurons. These results suggest that ghrelin acts to regulate food intake through synaptic connections in hypothalamic neuronal networks. 相似文献
5.
Functional defects in the fanconi anemia pathway in pancreatic cancer cells 总被引:17,自引:0,他引:17
下载免费PDF全文
![点击此处可从《The American journal of pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
van der Heijden MS Brody JR Gallmeier E Cunningham SC Dezentje DA Shen D Hruban RH Kern SE 《The American journal of pathology》2004,165(2):651-657
Biallelic BRCA2-mutations can cause Fanconi anemia and are found in approximately 7% of pancreatic cancers. Recently, several sequence changes in FANCC and FANCG were reported in pancreatic cancer. Functional defects in the Fanconi pathway can result in a marked hypersensitivity to interstrand crosslinking agents, such as mitomycin C. The functional implications of mutations in the Fanconi pathway in cancer have not been fully studied yet; these studies are needed to pave the way for clinical trials of treatment with crosslinking agents of Fanconi-defective cancers. The competence of the proximal Fanconi pathway was screened in 21 pancreatic cancer cell lines by an assay of Fancd2 monoubiquitination using a Fancd2 immunoblot. The pancreatic cancer cell lines Hs766T and PL11 were defective in Fancd2 monoubiquitination. In PL11, this defect led to the identification of a large homozygous deletion in FANCC, the first cancer cell line found to be FANCC-null. The Fanconi-defective cell lines Hs766T, PL11, and CAPAN1 were hypersensitive to the crosslinking agent mitomycin C and some to cis-platin, as measured by cell survival assays and G(2)/M cell-cycle arrest. These results support the practical exploration of crosslinking agents for non-Fanconi anemia patients that have tumors defective in the Fanconi pathway. 相似文献
6.
The contribution of group III and IV muscle nociceptors activated by injection of KCl or bradykinin into the muscle artery (i.a.) of the gastrocnemius-soleus muscle to spinal motor reflex pathways was investigated in high spinal cats. Group I-III fibres were completely blocked by TTX, leaving group IV-fibre conduction intact. Thus, effects from i.a. KCl or bradykinin injection persisting after TTX were attributed to TTX resistant group IV fibres while the contribution of group III fibres was approximately defined by the difference between those effects and the control effects before TTX. Confirming former findings the chemical activation of group III and IV muscle afferents induced distinct reflex facilitation of the flexor posterior biceps semitendinosus and inhibition of the extensor quadriceps. After the block of all myelinated fibres by TTX the same stimuli induced only minor reflex effects mediated by the persistently conducting TTX resistant group IV afferents. It is concluded that the main functional meaning of group IV muscle afferents, which respond preferentially with a higher threshold to mechanical stimuli, is probably less related to reflex motor control than that of group III afferents. 相似文献
7.
When tracking moving visual stimuli, primates orient their visual axis by combining two kinds of eye movements, smooth pursuit and saccades, that have very different dynamics. Yet, the mechanisms that govern the decision to switch from one type of eye movement to the other are still poorly understood, even though they could bring a significant contribution to the understanding of how the CNS combines different kinds of control strategies to achieve a common motor and sensory goal. In this study, we investigated the oculomotor responses to a large range of different combinations of position error and velocity error during visual tracking of moving stimuli in humans. We found that the oculomotor system uses a prediction of the time at which the eye trajectory will cross the target, defined as the "eye crossing time" (T(XE)). The eye crossing time, which depends on both position error and velocity error, is the criterion used to switch between smooth and saccadic pursuit, i.e., to trigger catch-up saccades. On average, for T(XE) between 40 and 180 ms, no saccade is triggered and target tracking remains purely smooth. Conversely, when T(XE) becomes smaller than 40 ms or larger than 180 ms, a saccade is triggered after a short latency (around 125 ms). 相似文献
8.
D. Blohm S. Kaalund B.W. Jakobsen 《Scandinavian journal of medicine & science in sports》1999,9(4):245-247
A case of an acute traction apophysitis, "little league elbow", in an adolescent badminton player is presented. After a period of intense badminton activity, the patient developed typical signs of inflammation related to his elbow. X-ray showed soft tissue calcifications and ultrasound showed intra-articular swelling and a possible apophysitis related to the elbow. After a period of immobilization followed by low activity he could return to normal sports activity. 相似文献
9.
Michiel S van der Heijden Jonathan R Brody David A Dezentje Eike Gallmeier Steven C Cunningham Michael J Swartz Angelo M DeMarzo G Johan A Offerhaus William H Isacoff Ralph H Hruban Scott E Kern 《Clinical cancer research》2005,11(20):7508-7515
PURPOSE: BRCA2, FANCC, and FANCG gene mutations are present in a subset of pancreatic cancer. Defects in these genes could lead to hypersensitivity to interstrand cross-linkers in vivo and a more optimal treatment of pancreatic cancer patients based on the genetic profile of the tumor. EXPERIMENTAL DESIGN: Two retrovirally complemented pancreatic cancer cell lines having defects in the Fanconi anemia pathway, PL11 (FANCC-mutated) and Hs766T (FANCG-mutated), as well as several parental pancreatic cancer cell lines with or without mutations in the Fanconi anemia/BRCA2 pathway, were assayed for in vitro and in vivo sensitivities to various chemotherapeutic agents. RESULTS: A distinct dichotomy of drug responses was observed. Fanconi anemia-defective cancer cells were hypersensitive to the cross-linking agents mitomycin C (MMC), cisplatin, chlorambucil, and melphalan but not to 5-fluorouracil, gemcitabine, doxorubicin, etoposide, vinblastine, or paclitaxel. Hypersensitivity to cross-linking agents was confirmed in vivo; FANCC-deficient xenografts of PL11 and BRCA2-deficient xenografts of CAPAN1 regressed on treatment with two different regimens of MMC whereas Fanconi anemia-proficient xenografts did not. The MMC response comprised cell cycle arrest, apoptosis, and necrosis. Xenografts of PL11 also regressed after a single dose of cyclophosphamide whereas xenografts of genetically complemented PL11(FANCC) did not. CONCLUSIONS: MMC or other cross-linking agents as a clinical therapy for pancreatic cancer patients with tumors harboring defects in the Fanconi anemia/BRCA2 pathway should be specifically investigated. 相似文献
10.